1 / 40

Clinical Assessment of Neurotoxicity

Clinical Assessment of Neurotoxicity. Occupational and Environmental Medical Association of Canada 29th Annual Scientific Conference. Chris Martin, MD, MSc, FRCPC cmartin@hsc.wvu.edu Director, Institute of Occupational and Environmental Health.

kuniko
Download Presentation

Clinical Assessment of Neurotoxicity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clinical Assessment of Neurotoxicity Occupational and Environmental Medical Association of Canada 29th Annual Scientific Conference Chris Martin, MD, MSc, FRCPC cmartin@hsc.wvu.edu Director, Institute of Occupational and Environmental Health

  2. These are among the most challenging cases in Occupational Medicine

  3. “Many complain of their Memory, few of their Judgment”. - Benjamin Franklin “Tout le monde se plaint de sa mémoire, et personne ne se plaint de son jugement”. - François de la Rochefoucauld

  4. Overview • Review neuroanatomy • Vulnerability • Targets of neurotoxicity • Clinical approach • Case discussion

  5. 1. Review of Neuroanatomy

  6. What makes the nervous system LESS vulnerable? • Blood brain barrier for CNS

  7. What makes the nervous system LESS vulnerable? • Excess neuronal capacity

  8. What makes the Nervous System MORE vulnerable? • High aerobic energy requirements • Most sensitive tissue to loss of oxygen supply • Presence of long, complex cell structures • Axons are most sensitive to damage

  9. Structure of the Neuron

  10. Targets of Neurotoxicity Damage to: • Cell body • neuronopathy • Axon • axonopathy • Myelin • myelinopathy • Synapse or neuromuscular junction • “transmissionopathy”

  11. Neuronopathy • Damage is irreversible

  12. Neuronopathy • Damage is irreversible Examples: • methyl mercury • MPTP

  13. Axonopathy • Damage is reversible in PNS irreversible in CNS • Sensorimotor neuropathies • “Stocking and glove” distribution

  14. Axonopathy • Damage is reversible in PNS irreversible in CNS • Sensorimotor neuropathies • “Stocking and glove”distribution Examples: • carbon disulfide • n-hexane • acrylamide monomer • arsenic • trichloroethylene

  15. Myelinopathy • lead

  16. “Transmissionopathy” • Organophosphate pesticides

  17. 2. Clinical Approach

  18. What is the typical case before you? • CNS: Chronic encephalopathy • PNS: Sensorimotor peripheral neuropathy

  19. History • Take a detailed exposure history • Strong dose-response relationship

  20. History • Take a detailed exposure history • Ask about symptoms of acute intoxication for any body system when actively exposed

  21. History • Take a detailed exposure history • Ask about symptoms of acute intoxication for any body system when actively exposed Example: For solvents, dermatitis? Headache? Nausea? Felt drunk? Syncope?

  22. History • Obtain detailed information about symptoms • Ask for examples of symptom manifestations • Functional status, activities of daily living

  23. History • Obtain detailed information about symptoms • Determine chronology of symptoms in relation to exposure • Symptoms occur at the time of or shortly after exposure • Course of symptoms after cessation of exposure important

  24. History • Obtain detailed information about symptoms • Determine chronology of symptoms in relation to exposure • Complete medical history to ascertain other possible causes • Alcohol, cardiovascular disease, psychiatric disease, family history

  25. Physical Examination • Folstein Mini-Mental Status Exam

  26. Physical Examination • Folstein Mini-Mental Status Exam • Detailed neurological examination • Particular attention to nature and distribution of any abnormalities

  27. Investigations Peripheral Nervous System: • Nerve conduction studies / electromyography • Quantitative sensory testing • Nerve biopsy if n-hexane peripheral neuropathy

  28. Peripheral Nervous System • Key points in formulating diagnosis: • Most toxic neuropathies are symmetric with greater distal involvement • Recovery following cessation of exposure • In general, for about 25-40% of peripheral neuropathies, diagnosis is unknown

  29. Investigations Central Nervous System: • Imaging studies usually normal unless very advanced disease • Other investigations (lumbar puncture, EEG, labs) to rule out other causes • Most sensitive investigation is neuropsychiatric testing • Testing is user dependent • Report should provide numerical scores on test • Read the entire report • Include investigations for effects of exposure on other systems (Example LFT’s for solvents)

  30. Central Nervous System • Key points in formulating diagnosis: • Most toxic CNS disorders are diffuse without focal pathology • Onset when exposed • Stable following cessation of exposure for chronic solvent encephalopathy1 • Must rule out other causes • May need longitudinal information • Consider the impact of a diagnosis of “brain damage” from “chemical poisoning” 1. van Valen E, Wekking E, van der Laan G, Sprangers M, van Dijk F. The course of chronic solvent induced encephalopathy: A systematic review. Neurotoxicology. 2009 Nov;30(6):1172-86.

  31. 3. Case Discussion

  32. Case Discussion • 39-year old female clerk at prison facility • Exposed to sewer gases as well as agents applied to unclog commodes • At 1:30 PM upper airway irritation, headache, nausea with vomiting • Left work at 2:50 PM

  33. Case Discussion 3 days later: • difficulty with concentration, poor memory, photophobia, difficulty speaking, reduced smell and taste, difficulty writing • Very poor level of functioning since exposure • Presents to ER one week after exposure

  34. Case Discussion Physical exam: • Mental status - poor recall, serial 7’s, good judgement, general knowledge • Performs tasks after approximately 3 second delay • Reduced olfaction, otherwise cranial nerves intact • Photophobia

  35. Case Discussion Physical exam: • Difficulty with alternating movements, finger-nose, tandem gait • Romberg’s sign negative • Power, tone, reflexes, sensation intact • Aphasia: rhythmic quality, selective omission of articles

  36. Case Discussion Do you think her presentation is due to the exposure?

  37. Case Discussion Do you think her presentation is due to the exposure? • Not a high level exposure, not likely to have been exposed to compatible neurotoxic agent

  38. Case Discussion Do you think her presentation is due to the exposure? • Not a high level exposure, not likely to have been exposed to compatible neurotoxic agent • Delay in symptoms

More Related